Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

A medication already prescribed to relieve menopausal symptoms could also help prevent invasive breast cancer. That's the ...

"Medications that affect hormone levels may also cause hot flashes," adds Nonacs. She lists inhibitors that are taken for breast cancer and some medications that are prescribed to treat ...

Bayer’s hot flash drug candidate has hit the mark in a phase 3 breast cancer trial, potentially positioning the German drugmaker to get the jump on Astellas’ rival drug Veozah. Astellas won ...